Clinical features of cases of orbital granulocytic sarcoma (OGS)
| Case | Age | Sex | Proptosis | Presentation | Interval |
|---|---|---|---|---|---|
| 1 | 9 years | Male | R | OGS | 11 months |
| 2 | 9 years | Female | L | OGS | 25 days |
| 3 | 11 years | Female | R | OGS | 3 months |
| 4 | 10 years | Male | L | OGS | 3 months |
| 5 | 5 months | Male | L | OGS and leukaemia | Simultaneous |
| 6 | 8 years | Male | R | OGS and leukaemia | Simultaneous |
| 7 | 14 years | Male | R | Leukaemia | 8 months’ remission |
↵All seven patients presented with rapidly progressive proptosis.
↵OGS denotes patients who presented with orbital granulocytic sarcoma before any evidence of systemic leukaemia. OGS and leukaemia denotes patients who developed orbital granulocytic sarcoma and leukaemia simultaneously. Leukaemia denotes patients who had leukaemia before developing orbital granulocytic sarcoma.
↵Time interval between orbital granulocytic sarcoma and systemic leukaemia.